Natural Killer Cells Therapeutics Market - Global Outlook and Forecast 2023-2028

Report ID: 1567089 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Natural Killer Cells Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Natural Killer Cells Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cells Therapeutics Overall Market Size
    2.1 Global Natural Killer Cells Therapeutics Market Size: 2021 VS 2028
    2.2 Global Natural Killer Cells Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Natural Killer Cells Therapeutics Players in Global Market
    3.2 Top Global Natural Killer Cells Therapeutics Companies Ranked by Revenue
    3.3 Global Natural Killer Cells Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Natural Killer Cells Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Natural Killer Cells Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cells Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Natural Killer Cells Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Natural Killer Cells Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 NK Cell Therapies
        4.1.3 NK Cell Directed Antibodies
    4.2 By Type - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
        5.1.2 Cancer
        5.1.3 Gastrointestinal Diseases
        5.1.4 Immunoproliferative Disorders
        5.1.5 Others
    5.2 By Application - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Natural Killer Cells Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Natural Killer Cells Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Natural Killer Cells Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Natural Killer Cells Therapeutics Revenue, 2017-2028
        6.3.2 US Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.3.3 Canada Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Natural Killer Cells Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Natural Killer Cells Therapeutics Revenue, 2017-2028
        6.4.2 Germany Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.3 France Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.5 Italy Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.6 Russia Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Natural Killer Cells Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Natural Killer Cells Therapeutics Revenue, 2017-2028
        6.5.2 China Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.5.3 Japan Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.5.6 India Natural Killer Cells Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Natural Killer Cells Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Natural Killer Cells Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.7.3 Israel Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Natural Killer Cells Therapeutics Market Size, 2017-2028
        6.7.5 UAE Natural Killer Cells Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Affimed
        7.1.1 Affimed Corporate Summary
        7.1.2 Affimed Business Overview
        7.1.3 Affimed Natural Killer Cells Therapeutics Major Product Offerings
        7.1.4 Affimed Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Affimed Key News
    7.2 Celgene
        7.2.1 Celgene Corporate Summary
        7.2.2 Celgene Business Overview
        7.2.3 Celgene Natural Killer Cells Therapeutics Major Product Offerings
        7.2.4 Celgene Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Celgene Key News
    7.3 Fate Therapeutics
        7.3.1 Fate Therapeutics Corporate Summary
        7.3.2 Fate Therapeutics Business Overview
        7.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Fate Therapeutics Key News
    7.4 Fortress Biotech
        7.4.1 Fortress Biotech Corporate Summary
        7.4.2 Fortress Biotech Business Overview
        7.4.3 Fortress Biotech Natural Killer Cells Therapeutics Major Product Offerings
        7.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Fortress Biotech Key News
    7.5 Glycostem Therapeutics
        7.5.1 Glycostem Therapeutics Corporate Summary
        7.5.2 Glycostem Therapeutics Business Overview
        7.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Glycostem Therapeutics Key News
    7.6 Innate Pharma
        7.6.1 Innate Pharma Corporate Summary
        7.6.2 Innate Pharma Business Overview
        7.6.3 Innate Pharma Natural Killer Cells Therapeutics Major Product Offerings
        7.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Innate Pharma Key News
    7.7 Nantkwest
        7.7.1 Nantkwest Corporate Summary
        7.7.2 Nantkwest Business Overview
        7.7.3 Nantkwest Natural Killer Cells Therapeutics Major Product Offerings
        7.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Nantkwest Key News
    7.8 Nkarta Therapeutics
        7.8.1 Nkarta Therapeutics Corporate Summary
        7.8.2 Nkarta Therapeutics Business Overview
        7.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Nkarta Therapeutics Key News
    7.9 NKT Therapeutics
        7.9.1 NKT Therapeutics Corporate Summary
        7.9.2 NKT Therapeutics Business Overview
        7.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 NKT Therapeutics Key News
    7.10 Ziopharm Oncology
        7.10.1 Ziopharm Oncology Corporate Summary
        7.10.2 Ziopharm Oncology Business Overview
        7.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Major Product Offerings
        7.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Ziopharm Oncology Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Natural Killer Cells Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Natural Killer Cells Therapeutics Market Drivers in Global Market
    Table 3. Natural Killer Cells Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Natural Killer Cells Therapeutics in Global Market
    Table 5. Top Natural Killer Cells Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Natural Killer Cells Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Natural Killer Cells Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Natural Killer Cells Therapeutics Product Type
    Table 9. List of Global Tier 1 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Natural Killer Cells Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Natural Killer Cells Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Affimed Corporate Summary
    Table 31. Affimed Natural Killer Cells Therapeutics Product Offerings
    Table 32. Affimed Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Celgene Corporate Summary
    Table 34. Celgene Natural Killer Cells Therapeutics Product Offerings
    Table 35. Celgene Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Fate Therapeutics Corporate Summary
    Table 37. Fate Therapeutics Natural Killer Cells Therapeutics Product Offerings
    Table 38. Fate Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Fortress Biotech Corporate Summary
    Table 40. Fortress Biotech Natural Killer Cells Therapeutics Product Offerings
    Table 41. Fortress Biotech Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Glycostem Therapeutics Corporate Summary
    Table 43. Glycostem Therapeutics Natural Killer Cells Therapeutics Product Offerings
    Table 44. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Innate Pharma Corporate Summary
    Table 46. Innate Pharma Natural Killer Cells Therapeutics Product Offerings
    Table 47. Innate Pharma Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Nantkwest Corporate Summary
    Table 49. Nantkwest Natural Killer Cells Therapeutics Product Offerings
    Table 50. Nantkwest Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Nkarta Therapeutics Corporate Summary
    Table 52. Nkarta Therapeutics Natural Killer Cells Therapeutics Product Offerings
    Table 53. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. NKT Therapeutics Corporate Summary
    Table 55. NKT Therapeutics Natural Killer Cells Therapeutics Product Offerings
    Table 56. NKT Therapeutics Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Ziopharm Oncology Corporate Summary
    Table 58. Ziopharm Oncology Natural Killer Cells Therapeutics Product Offerings
    Table 59. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Natural Killer Cells Therapeutics Segment by Type in 2021
    Figure 2. Natural Killer Cells Therapeutics Segment by Application in 2021
    Figure 3. Global Natural Killer Cells Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Natural Killer Cells Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Natural Killer Cells Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2021
    Figure 8. By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Natural Killer Cells Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Affimed Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Celgene Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Fate Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Fortress Biotech Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Innate Pharma Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Nantkwest Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. NKT Therapeutics Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Ziopharm Oncology Natural Killer Cells Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Natural Killer Cells Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Natural Killer Cells Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Natural Killer Cells Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports